Search for " " - 2/178

Results for “ ”

Entry	Author	Date	Location
Oncorus Adds $79.5M to Steer Cancer-Fighting Virus to Human Testing	Frank Vinluan	08/21/19	Boston
Elanco’s $7.6B Deal With Bayer Bolsters Pets, Farm Animals Footprint	Frank Vinluan	08/20/19	Indiana
FDA Rejects Sarepta’s Second Duchenne Drug, Citing Safety Concerns	Ben Fidler	08/19/19	Boston
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs	Frank Vinluan	08/16/19	New York
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More	Alex Lash	08/16/19	National
Will Porsche Fans Ever Live in a Driverless World? Porsche Says No.	Bernadette Tansey	08/16/19	San Francisco
Four New Drugs Are Around the Corner. Here’s What You Need to Know.	Ben Fidler	08/15/19	National
After Drought, Digital Health’s Summer of IPOs Brings Validation	Jeff Buchanan	08/14/19	National
Mason Raises $25M to Help Software Firms Deploy, Manage Applications	Jeff Buchanan	08/14/19	Seattle
Bio Roundup: Surprise News, a Gene Therapy Mess & a CAR-T Step	Ben Fidler	08/09/19	National
Bayer Buys Out BlueRock, Betting at Least $240M More on Cell Therapy Work	Ben Fidler	08/08/19	Boston
FDA: Despite “Manipulated” Data, $2M Gene Therapy Should Stay on Market	Ben Fidler	08/06/19	National
Another Delay for Intra-Cellular as FDA Extends Review of Psych Drug	Frank Vinluan	08/05/19	New York
GlycoMimetics Sickle Cell Drug Flops as Others Creep Forward	Ben Fidler	08/05/19	New York
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More	Frank Vinluan	08/02/19	National
Amicus Offers First Look At Gene Therapy Work With Batten’s Data	Ben Fidler	08/01/19	New York
White House Floats Canadian Import Plan But Excludes Many Costly Drugs	Frank Vinluan	07/31/19	National
Mark Levin Named Xconomy’s 2019 Lifetime Achievement Award Winner in Boston	Angela Shah	07/31/19	National
Upjohn & Mylan to Merge, Freeing Pfizer to Focus on Biopharma R&D	Frank Vinluan	07/29/19	New York
Merck Data Are Another Step for Immunotherapy in Breast Cancer	Ben Fidler	07/29/19	New York
Duchenne Advocates Start Casimir, Aiming to Capture Missing Data	Ben Fidler	07/26/19	Boston
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More	Ben Fidler	07/26/19	National
No Co-Founder? Y Combinator Offers Matchmaking at Startup School	Bernadette Tansey	07/26/19	San Francisco
As Castle Bio Jumps on IPO Train, Industry Trends Suggest Slowdown	Frank Vinluan	07/25/19	National
Bristol, With Another Lung Cancer Flop, Loses More Ground to Merck	Ben Fidler	07/24/19	New York
Freenome Snags $160M to Boost Blood Test for Early Cancer Detection	Bernadette Tansey	07/24/19	San Francisco
TScan Lands $48M for Better, Safer T-Cell Receptor Cancer Therapies	Frank Vinluan	07/24/19	Boston
With Regulator’s Nod, Bosch Plans Spread of Driverless Valet Parking	Bernadette Tansey	07/23/19	San Francisco
Could Facebook’s Crypto Break Financial System? Congress Airs Fears	Bernadette Tansey	07/19/19	San Francisco
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More	Frank Vinluan	07/19/19	National
Page 2 of 148	« previous page · next page »